You just read:

Brain Cancer Patient Survival, Immune and Tumor Data from AIVITA Biomedical's Phase 2 Clinical Trial to be Presented at SITC Annual Meeting

News provided by

AIVITA Biomedical, Inc.

Nov 08, 2019, 14:31 ET